Emerging Strategies to Improve the Design and Manufacturing of Biocompatible Therapeutic Materials.

3D printing biodegradable materials controlled release encapsulation microparticles nanoparticles personalized medicine porous materials scaffolds

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
12 Jul 2023
Historique:
received: 11 05 2023
accepted: 14 06 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Currently, the field of medicine is drastically advancing, mainly due to the progress in emerging areas such as nanomedicine, regenerative medicine, and personalized medicine. For example, the development of novel drug delivery systems in the form of nanoparticles is improving the liberation, absorption, distribution, metabolism, and excretion (LADME) properties of the derived formulations, with a consequent enhancement in the treatment efficacy, a reduction in the secondary effects, and an increase in compliance with the dosage guidelines. Additionally, the use of biocompatible scaffolds is translating into the possibility of regenerating biological tissues. Personalized medicine is also benefiting from the advantages offered by additive manufacturing. However, all these areas have in common the need to develop novel materials or composites that fulfill the requirements of each application. Therefore, the aim of this Special Issue was to identify novel materials/composites that have been developed with specific characteristics for the designed biomedical application.

Identifiants

pubmed: 37514123
pii: pharmaceutics15071938
doi: 10.3390/pharmaceutics15071938
pmc: PMC10383592
pii:
doi:

Types de publication

Editorial

Langues

eng

Références

Pharmaceutics. 2021 May 14;13(5):
pubmed: 34069254
Pharmaceutics. 2022 May 27;14(6):
pubmed: 35745711
Pharmaceutics. 2022 Feb 21;14(2):
pubmed: 35214186
Pharmaceutics. 2022 Oct 10;14(10):
pubmed: 36297590
Pharmaceutics. 2022 Mar 30;14(4):
pubmed: 35456582
Pharmaceutics. 2022 Aug 23;14(9):
pubmed: 36145500
Pharmaceutics. 2022 Apr 08;14(4):
pubmed: 35456654
Pharmaceutics. 2021 Aug 17;13(8):
pubmed: 34452243
Pharmaceutics. 2022 Jun 12;14(6):
pubmed: 35745816

Auteurs

Guillermo Martínez (G)

Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

Juan Vázquez (J)

Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, 41012 Sevilla, Spain.

Belén Begines (B)

Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

Ana Alcudia (A)

Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.

Classifications MeSH